Assessing the Impact of the Personalized Medicine Clinic on Mental Health Outcomes

ConditionsMental Health Depressive Disorder Pharmacogenetic Testing Antidepressant

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The aim of this study is to investigate if personalized dosing of antidepressant medications using information gathered at the Personalized Medicine Clinic can improve patients' mental health. The main question it aims to answer is if the Personalized Medicine Clinic can improve depressive symptoms based on the CES-D survey score.

Eligibility criteria

Qualifiers

Depressive symptoms

Disqualifiers

Patients who do not speak English

Patients with severe mental illness including hospitalized patients or patients with suicidal ideation

Trial design

Treatments tested in this trial

Personalized Medicine Clinic

Treatment groups

200 Participants

are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

Source ClinicalTrials.gov